Brief: Annexin Pharmaceuticals patent approved in the United States

Annexin Pharmaceuticals AB (publ)

20/06/2017 07:33

June 20 (Reuters) - ANNEXIN PHARMACEUTICALS AB (PUBL)  ANNX.ST : 
    * PATENT FOR TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL DISEASE APPROVED IN UNITED 
STATES 
    * US PATENT IS VALID UNTIL DECEMBER 2028 
 
Source text for Eikon:  ID:nWkr7hbwyY  
Further company coverage:  ANNX.ST  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))